DeepSeq.AI Announces Presentation at SynBioBeta Conference on May 5, 2026
FOSTER CITY, CA, UNITED STATES, April 20, 2026 /EINPresswire.com/ -- DeepSeq.AI, Inc. (DeepSeq), a privately held biotech company transforming AI-based protein drug discovery using hyperscaled data, announced today that Andrew Chang, DeepSeq' …